News
VINC
0.8771
-5.69%
-0.0529
Weekly Report: what happened at VINC last week (0422-0426)?
Weekly Report · 4d ago
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Aon plc shares fell 7.4% to $283.19 on Friday. The company reported worse-than-expected quarterly financial results. Biodexa Pharmaceuticals Plc shares jumped 73.3% after the company signed a deal with eRapa. Snap Inc. Shares jumped 23% in the mid-day session.
Benzinga · 04/26 17:56
Why Vincerx Pharma (VINC) Stock Is Falling
Vincerx Pharma Inc (NASDAQ:VINC) shares are trading lower by 9.7% to $0.81. The company priced an underwritten public offering of 6 million shares of common stock with accompanying warrants. The offering is expected to raise approximately $16.5 million.
Benzinga · 04/26 15:31
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Shares of Alphabet Inc. Rose sharply in today's pre-market trading. The company reported upbeat results for its first quarter. Tevogen Bio Holdings Inc. Shares gained 64.7% after falling over 43% on Thursday. Skechers U.S.A., Inc. And Snap Inc. Also rose in pre- market trading.
Benzinga · 04/26 12:18
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tevogen Bio Holdings (NASDAQ:TVGN) shares rose 75.3% to $1.49 during Friday's pre-market session. Cryo-Cell International (AMEX:CCEL) shares increased by 27.94% during the session. Fresh2 Group shares moved upwards by 18.33%.
Benzinga · 04/26 12:06
Vincerx Pharma dips 16%, prices $16M stock
Vincerx Pharma dips 16%, prices $16M stock. The stock price dipped 16% on Friday during pre-market hours of trade. The offering is expected to close on or about April 30, 2024. Gross proceeds are expected to be $16.5M.
Seeking Alpha · 04/26 09:33
Vincerx Pharma Sets Pricing For New Public Offering Of Shares And Warrants
Vincerx Pharma, Inc. Announces pricing of an underwritten public offering of 6,000,000 shares of its common stock. The company also plans to sell pre-funded warrants to purchase up to 16,000,.000 shares. Each share of common stock is being sold together at a combined public offering price of $0.75.
Benzinga · 04/26 06:29
*Vincerx Pharma Expects Offering to Close on or About April 30 >VINC
Dow Jones · 04/26 04:37
*Vincerx Pharma Prices $16.5M Offering of Common Stock and Warrants >VINC
Dow Jones · 04/26 04:36
VINCERX PHARMA INC - PRICING OF AN UNDERWRITTEN PUBLIC OFFERING OF 16 MLN SHARES OF ITS COMMON STOCK AT A COMBINED PRICE OF $0.75 PER SHR
Reuters · 04/26 04:27
12 Health Care Stocks Moving In Thursday's After-Market Session
Tevogen Bio Holdings (NASDAQ:TVGN) shares rose 51.8% to $1.29 during Thursday's after-market session. Fresh2 Group stock rose 10.61% and ResMed stock rose 6.85% in the same session. The company's Q3 earnings came out today.
Benzinga · 04/25 20:32
Vincerx Pharma Announces Proposed Underwritten Public Offering Of Common Stock And Warrants; No Size Or Amount Disclosed
Vincerx Pharma, Inc. Announced a proposed underwritten public offering of shares of its common stock. The offering is subject to market and other conditions. All of the shares, pre-funded warrants and common stock warrants in the proposed offering will be offered by the company.
Benzinga · 04/25 20:21
VINCERX PHARMA ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK AND WARRANTS
Reuters · 04/25 20:01
*Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stk and Warrants >VINC
Dow Jones · 04/25 20:01
Weekly Report: what happened at VINC last week (0415-0419)?
Weekly Report · 04/22 11:32
Weekly Report: what happened at VINC last week (0408-0412)?
Weekly Report · 04/15 11:23
Vincerx Pharma Inc (VINC) Gets a Buy from Leerink Partners
TipRanks · 04/10 06:21
Crude Oil Down Over 1%; Cognyte Software Shares Plummet
U.S. Stocks traded lower toward the end of trading on Tuesday. The Dow traded down 0.46% while the NASDAQ fell 0.24%. The S&P 500 fell around 0.4% and European shares closed lower. Real estate shares jumped by 0.8% in Asian markets. The NFIB Small Business Optimism Index declined for a third straight month.
Benzinga · 04/09 18:34
BUZZ-U.S. STOCKS ON THE MOVE-Chemours, Lucid, OppFi
U.S. Stocks reverse early gains ahead of key inflation print. Dow Jones Industrial Average down 0.36%; S&P 500 and Nasdaq Composite also down. Chemours, Lucid, OppFi among the top stocks on the move. Lucid Group down 3.9% after announcing potential sale of parts of company.
Reuters · 04/09 18:19
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
NASDAQ · 04/09 17:34
More
Webull provides a variety of real-time VINC stock news. You can receive the latest news about Vincerx Pharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About VINC
Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing differentiated and novel therapies to address the unmet medical needs of patients with cancer. It has a next generation bioconjugation platform, called VersAptx. The VersAptx platform is a versatile and adaptable, next generation bioconjugation platform. Its product candidates include VIP943 (CD123-KSPi), VIP924 (CXCR5-KSPi), VIP236, and Enitociclib (P-TEFb/CDK9 inhibitor). VIP943 is a potential anti-CD123 ADC created with its VersAptx Platform. It consists of an anti-CD123 antibody, a novel legumain-cleavable linker, and a KSPi payload enhanced with its CellTrapper technology. Enitociclib is a selective CDK9 inhibitor. Enitociclib effectively blocks P-TEFb-mediated activation of RNA polymerase II, preventing transcription of MCL1 and MYC, proteins associated with poor prognosis in various types of cancer.